Results are out ======================== Convalo Health International Posts Record Revenue and Profitability for the Quarter Ending November 30, 2015; Appoints New Chief Executive Officer; Announces Change in Fiscal Year End ccnm LOS ANGELES, CALIFORNIA--(Marketwired - Jan. 25, 2016) - Convalo Health International, Corp. ("Convalo") (TSX VENTURE:CXV), a company focused on the US addiction rehabilitation market, is pleased to announce a record quarter of revenue and Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) for the quarter ending November 30, 2015. Convalo's 2015 fourth quarter financial statements and accompanying Management's Discussion & Analysis (MD&A) are available at www.sedar.com. All amounts are in Canadian dollars and are based on our interim consolidated financial statements and accompanying MD&A for the quarter and twelve months ended November 30, 2015 and related notes prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted. Financial Highlights: For the 4th fiscal quarter ending November 30, 2015 revenues exceeded $8 million, an increase of 42% from the previous quarter. Revenue growth trend since launch: $5.7 million of revenue generated for the 3rd fiscal quarter ending August 30, 2015. $2.3 million of revenue generated for the 2nd fiscal quarter ending May 31, 2015. $1.2 million of revenue generated for the 1st fiscal quarter ending February 28, 2015. $345,000 of revenue generated for the 4th fiscal quarter ending November 30, 2014. Increased investment in sales and marketing spending by $1 million over the prior quarter in advance of establishing a national footprint by the end of 2016. Adjusted EBITDA(1) before investment in sales and marketing for the fourth quarter was $2.8 million, a more than 70% increase in profit for the second consecutive quarter. Adjusted operating margin(2), which excludes general and administration costs, consisting primarily of corporate overhead such as public company costs, were in excess of 37% for the quarter. Cash on the balance sheet as of November 30, 2015, was $24 million.